CTDNEP1-deficiency-induced tumors resemble the histopathological, transcriptomic, and clinical features of human G3 MB counterparts, suggesting that CTDNEP1 is a potent tumor suppressor in the highly aggressive MYC-driven G3 MBs. Here, CTDNEP1 is linked to neoplasm.